CFIA
NVO

Cantor Fitzgerald Investment Advisors’s Novo Nordisk NVO Stock Holding History

Cantor Fitzgerald Investment Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.3M Buy
214,075
+177,100
+479% +$7.61M 0.69% 57
2026
Q1 		$1.36M Sell
36,975
-5,125
-12% -$243K 0.1% 113
2025
Q4 		$2.14M Buy
42,100
+18,775
+80% +$960K 0.16% 98
2025
Q3 		$1.29M Buy
+23,325
New +$1.37M 0.09% 130

Other funds holding NVO

Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Cantor Fitzgerald Investment Advisors's NVO Position: Q2 2026 in Review

Cantor Fitzgerald Investment Advisors increased its Novo Nordisk (NVO) stake by 479% in Q2 2026, buying an estimated $7.61M and bringing the position to 214,075 shares worth $10.3M. The position accounts for 0.69% of the portfolio, ranked #57.

Cantor Fitzgerald Investment Advisors first reported a position in NVO in Q3 2025 and has held it in 4 quarters since. 1,126 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Cantor Fitzgerald Investment Advisors held 214,075 shares of Novo Nordisk worth $10.3M as of Q2 2026.
  • Cantor Fitzgerald Investment Advisors bought 177,100 Novo Nordisk shares in Q2 2026, an estimated $7.61M.
  • Novo Nordisk made up 0.69% of Cantor Fitzgerald Investment Advisors's portfolio in Q2 2026, its #57 holding.
  • Cantor Fitzgerald Investment Advisors first reported a position in Novo Nordisk in Q3 2025 and has held it in 4 quarters since.
  • 1,126 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Cantor Fitzgerald Investment Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.